Part of the Clarifi Group

Strategy That Speaks Regulation.

Clarifi Strategy helps startups and investors align regulatory readiness with business success — from due diligence to fundraising.

Part of the Clarifi Group

What We Do

We help innovators and investors make smarter, faster, and safer growth decisions.Our work includes:- Regulatory due diligence for venture funds and accelerators
- Pitch-deck and narrative support for startups raising capital
- Market-access strategy (EU, UK, US)
- Business-model × regulatory-fit analysis

CLARIFI.FI

For Startups

Turn Compliance into Investor Confidence.We help founders show investors that regulatory strategy is part of the growth story — not an afterthought.
We translate your milestones, CE marking, or FDA pathway into investor-ready proof points for your deck and data room.Example:
Founder Stephen O’Rourke contributed regulatory and operational insights to Infinite Roots (formerly Mushlabs) during its €50 million Series B raise, ensuring regulatory credibility matched investor ambition.

CLARIFI.FI

For VCs / Accelerators

De-Risk Your Portfolio — and Your Reputational Exposure.Clarifi provides tailored regulatory due-diligence assessments to support investment decisions.
We evaluate technical documentation, QMS maturity, and regulatory claims, identifying red flags before they become liabilities.Outputs include:- Rapid red-flag summary reports
- MDR/FDA status verification
- Regulatory roadmap & risk scoring
- Follow-up mentoring for portfolio companies

---

CLARIFI.FI

Why Clarifi

We sit at the intersection of compliance, strategy, and communication — turning regulatory language into business clarity.
That’s what makes Clarifi Strategy different: we don’t just check boxes; we translate compliance into competitive advantage.

Get In Touch

Whether you’re evaluating a startup or preparing to pitch one, let’s make your regulatory story a strategic asset. Get in touch below or at info(at)clarifi.fi

Submit

Clarifi in the Media

Insights and features on how regulation, innovation, and startup strategy intersect — from MedTech to FoodTech and beyond.Startups don’t just need tech leads: They need an integrator.
Feature for EU-Startups
Read →Confidential by Default? The Transparency Dilemma in Europe’s Novel Foods System.
Feature for Green Queen Media
Read →From Gatekeeping to Guiding: The Case for Collaborative Regulation in Mission-Driven Innovation
White Paper in Collaboration with GCI
Read →Digital Health Meets Red Tape: What Pharma Can Learn from Software as a Medical Device
The role of SaMD in pharma covering regulations, AI/ML risks, compliance, and digital health strategies.
Feature for PharmaNow
Read →Lessons from a €50 million Series B: And why it matters at every startup funding stage
Feature for EU-Startups
Read →What does Gourmey’s regulatory milestone mean for cell-cultivated meat?
Interviewed by FI Global Insights
Read →Why EU Innovators Face Growing Barriers With EU Combination Product Regulation
Interviewed by Medtech Insight
Read →From WHOOP to DiGA: Where the Wellness Line Becomes a Regulatory Minefield
Feature for Test Labs UK Outlook
Read →Guest article: EU novel food delays. Why bureaucracy is choking off food innovation
Feature for AgFunder News
Read →How AI can get your novel food approved faster
Interviewed by FoodNavigator Europe
Read →Apple vs WHOOP: Two Blood Pressure Strategies, Two Very Different Regulatory Journeys
Feature for Test Labs UK Outlook
Read →For interviews, collaborations, or speaking opportunities, contact info(at)clarifi.fi